BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 16, 2025
Big Pharma Giant Johnson & Johnson Reports Earnings That Beating Wall… Read More
© 2025 CSRXP- All Rights Reserved
Updates
CSRXP STATEMENT ON U.S. SENATE AND U.S. HOUSE REINTRODUCTION OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION, LOWER DRUG PRICES
Apr 15, 2025
Lawmakers Should Advance Bipartisan Solution to Crack Down on Anti-Competitive… Read More
THEY SAID IT! SENATE JUDICIARY CALLS OUT BIG PHARMA’S ANTI-COMPETITIVE PRACTICES THAT KEEP PRESCRIPTION DRUG PRICES HIGH
Apr 7, 2025
Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s… Read More
CSRxP STATEMENT ON SENATE JUDICIARY PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE, LOWER DRUG PRICES
Apr 3, 2025
Committee Markup Advances Legislation to Crack Down on Big Pharma’s… Read More
BIG PHARMA WATCH: PFIZER AVOIDED PAYING BILLIONS IN U.S. TAXES THROUGH “EGREGIOUS TAX GIMMICK”
Apr 2, 2025
Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute… Read More
FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS
Apr 2, 2025
BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION… Read More
CSRXP ANALYSIS FINDS BIG PHARMA’S DIRECT-TO-CONSUMER (DTC) ADVERTISING COSTS U.S. TAXPAYERS BILLIONS OF DOLLARS
Mar 18, 2025
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More
CSRXP APPLAUDS U.S. SENATE REINTRODUCTION OF BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES BY ADDRESSING BIG PHARMA’S PATENT ABUSE
Mar 14, 2025
Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and… Read More
They Said It!: Lawmakers And FDA Nominee Highlight Greater Competition As Critical To Lowering Prescription Drug Prices
Mar 12, 2025
U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious… Read More
ICYMI: CSRxP SURVEY FINDS AMERICAN VOTERS OVERWHELMINGLY HOLD BIG PHARMA RESPONSIBLE FOR HIGH DRUG PRICES
Mar 6, 2025
Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More
CSRXP: FABRIZIO WARD SURVEY FINDS AMERICAN VOTERS OVERWHELMING HOLD BIG PHARMA COMPANIES RESPONSIBLE FOR HIGH DRUG PRICES
Feb 28, 2025
Voters Across the Political Spectrum Identify Pharmaceutical Company Profits… Read More
SECOND OPINION: PhRMA REDUXES SAME DEBUNKED ARGUMENTS ON INNOVATION
Feb 26, 2025
Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather… Read More